• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS Back to Search Results
Model Number SN60WF
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cataract (1766); Blurred Vision (2137); Visual Impairment (2138)
Event Type  Injury  
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event Description
A customer reported following the implant of an intraocular lens (iol), she experienced blurry vision, a laser treatment, and decreased visual acuity.The lens was 'cloudy'.The patient also experienced a secondary cataract because of the implanted lens.Additional information was requested.This is one of two associated reports filed for this facility.This report is for the right eye of the patient.The alcon reference numbers are: (b)(4).
 
Manufacturer Narrative
Additional information provided.The manufacturer internal reference number is: (b)(4).
 
Event Description
Additional clarification received reports a laser treatment has not yet been performed, but is currently scheduled.The patient's visual acuity has decreased therefore the surgery was suggested.Additional information received reports the patient confused a secondary cataract with a cloudy lens.The patient was consulted and everything is reported as being 'okay.The lens is not cloudy but is reported to be in excellent condition.Additional follow up appointments will take place to monitor the patient.
 
Manufacturer Narrative
Additional information provided in g.1., g.2., h.3., h.6., and h.10.The product was not returned for analysis.The complaint history and product history records could not be reviewed because the reporting facility did not provide a lot number or any identification traceable to the manufacturing documentation.The product investigation could not identify a root cause for the reported complaint.Not enough information was provided from the account for further investigation.Information was provided by the patient that, "the ophthalmologist removed the deposits with a laser and since then with the "repaired" eye the patient can see 100% sharp again." the patient also reported that, "all problems regarding eye lens are currently solved." it was also provided that a follow up email was received from eye care professional (ecp).Ecp reported that," the issue has been solved.The patient confused a secondary cataract with a cloudy lens.After consulting the patient via phone on that day, everything is ok.Patient informed that they have no further issues and are satisfied.The iol is not cloudy but in excellent condition." the manufacturer internal reference number is: (b)(4).
 
Manufacturer Narrative
Additional information provided in a.2., d.1., d.2., d.3., d.4., g.1., g.2., h.4., and h.6.The manufacturer internal reference number is: (b)(4).
 
Manufacturer Narrative
Additional information provided in b.5., h.3., h.6., and h.10.The product was not returned for analysis.The root cause for the reported complaint could not be determined.Information was provided by the patient that, "the ophthalmologist removed the deposits with a laser and since then with the "repaired" eye the patient can see 100% sharp again." the patient also reported that, "all problems regarding eye lens are currently solved." it was also provided that a follow up email was received from eye care professional (ecp).Ecp reported that," the issue has been solved.The patient confused a secondary cataract with a cloudy lens.After consulting the patient via phone on that day, everything is ok.Patient informed that they have no further issues and are satisfied.The iol is not cloudy but in excellent condition." all product and batch history records are quality reviewed prior to product release.The manufacturer internal reference number is: (b)(4).
 
Event Description
Additional information received reports the patient confused a secondary cataract with a cloudy lens.The patient was consulted and everything is reported as being 'okay.The lens is not cloudy but is reported to be in excellent condition.Additional follow up appointments will take place to monitor the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ NATURAL SINGLEPIECE IOL
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork WV 00000
EI  00000
MDR Report Key9226462
MDR Text Key164130165
Report Number1119421-2019-01777
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
PMA/PMN Number
P930014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 02/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2021
Device Model NumberSN60WF
Device Catalogue NumberSN60WF.175
Device Lot Number21169622
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/25/2019
Initial Date FDA Received10/23/2019
Supplement Dates Manufacturer Received11/19/2019
12/20/2019
01/17/2020
02/17/2020
Supplement Dates FDA Received12/10/2019
01/06/2020
02/14/2020
02/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age77 YR
-
-